| 71. |
|
|
| 72. |
|
|
| 73. |
|
|
| 74. |
|
|
| 75. |
- Laaksonen, Marko, et al.
(author)
-
The association between muscle EMG and perfusion in knee extensor muscles
- 2006
-
In: Clinical Physiology and Functional Imaging. - 1475-0961 .- 1475-097X. ; 26:2, s. 99-105
-
Journal article (peer-reviewed)abstract
- The relationships between electromyographic (EMG) activity and force as well as muscle blood flow and work have been well established. However, the association between muscle blood flow and EMG activity remains unsolved. Thus, to test the hypothesis that muscle EMG activity relates to muscle perfusion in different compartments of the quadriceps femoris (QF) muscle, 12 healthy male subjects were studied. During two very submaximal exercise bouts, at different exercise intensities, oxygen labelled radiowater and positron emission tomography were used to measure muscle perfusion. In addition, produced force of knee extensors and muscle EMG activity in the vastus lateralis (VL), vastus medialis (VM) and rectus femoris (RF) muscles were recorded during both exercise bouts. Although the exercise intensity and average force production was higher during the second exercise bout (3815 vs. 5117 N; p=0.007), the mean EMG activity was lower (RF; p<0.001) or unchanged (VL; p=0.722 and VM; p=0.640). During the second exercise period, perfusion also remained unchanged in the entire QF muscle (p=0.223) and in its separate muscles (VL, p=0.703; VM, p=0.141; RF, p=0.113) in a group level. However, the individual changes in muscle perfusion were tightly related to changes in muscle EMG activity in VL (r=0.84; p=0.002) and in VM (r=0.68; p=0.015) but poorly in the RF muscle (r=0.40; p=0.257). In conclusion, the different associations between muscle perfusion and EMG activity in different QF muscles suggests specific functional role of the vasti muscles and the RF muscle.
|
|
| 76. |
|
|
| 77. |
- Norha, Jooa, et al.
(author)
-
Standing time and daily proportion of sedentary time are associated with pain-related disability in a one month accelerometer measurement in adults with overweight or obesity
- 2022
-
In: Scandinavian Journal of Pain. - Berlin : Walter de Gruyter. - 1877-8860 .- 1877-8879. ; 22:2, s. 317-324
-
Journal article (peer-reviewed)abstract
- The association between the subjective experience of pain-related disability (PRD) and device-measured physical activity (PA) and sedentary behavior (SB) in overweight and obese adults is not well known. The aim of this study was to investigate the associations of pain markers with accelerometer-measured SB duration and different intensities of PA among physically inactive middle-aged adults with overweight or obesity. This cross-sectional analysis included 72 subjects (27 men) with mean age of 57.9 (SD 6.7) years and mean BMI of 31.6 (SD 4.1) kg/m2. SB and standing time (ST), breaks in sedentary time, light physical activity (LPA) and moderate-to-vigorous physical activity (MVPA) were measured for four consecutive weeks (mean 25 days, SD 4) with a hip-worn triaxial accelerometer. Headache, musculoskeletal pain, back pain, and PRD were assessed by visual analog scales (VAS) and using the Oswestry disability index (ODI). RAND-36 questionnaire was applied to assess health-related quality of life. The associations were studied by linear models. ST was positively and SB proportion was negatively associated with PRD when adjusted for age, sex, BMI, accelerometry duration, MVPA, pain medication use, and general health perceptions assessed by RAND-36. No associations were found between ST and back pain. SB or different PA intensities were not associated with pain experience at specific sites. Longer daily ST, but not LPA or MVPA is associated with higher level of PRD. Correspondingly, higher proportion of SB is associated with lower level of PRD. This suggests that individuals with PRD prefer to stand, possibly to cope with pain. These results may highlight the importance of habitual standing behaviors in coping with experienced PRD in adults with overweight or obesity. © 2021 Walter de Gruyter GmbH, Berlin/Boston.
|
|
| 78. |
- Rissanen, Tuomas T., et al.
(author)
-
The bottleneck stent model for chronic myocardial ischemia and heart failure in pigs
- 2013
-
In: American Journal of Physiology. Heart and Circulatory Physiology. - : American Physiological Society. - 0363-6135 .- 1522-1539. ; 305:9, s. H1297-H1308
-
Journal article (peer-reviewed)abstract
- A large animal model of chronic myocardial ischemia and heart failure is crucial for the development of novel therapeutic approaches. In this study we developed a novel percutaneous one-and two-vessel model for chronic myocardial ischemia using a stent coated with a polytetrafluoroethylene tube formed in a bottleneck shape. The bottleneck stent was implanted in the proximal left anterior descending (LAD) or proximal circumflex artery (LCX), or in both proximal LCX and mid LAD 1 wk later (2-vessel model), and pigs were followed for 4-5 wk. Ejection fraction (EF), infarct size, collateral growth, and myocardial perfusion were assessed. Pigs were given antiarrhythmic medication to prevent sudden death. The occlusion time of the bottleneck stent and the timing of myocardial infarction could be modulated by the duration of antiplatelet medication. Fractional flow reserve measurements and positron emission tomography imaging showed severe ischemia after bottleneck stenting covering over 50% of the left ventricle in the proximal LAD model. Complete coronary occlusion was necessary for significant collateral growth, which mostly had occurred already during the first wk after the stent occlusion. Dynamic and competitive collateral growth patterns were observed. EF declined from 64 to 41% in the LCX model and to 44% in the LAD model 4 wk after stenting with 12 and 21% infarcted left ventricle in the LCX and LAD models, respectively. The mortality was 32 and 37% in the LCX and LAD models but very (71%) high in the two-vessel disease model. The implantation of a novel bottleneck stent in the proximal LAD or LCX is a novel porcine model of reversible myocardial ischemia (open stent) and ischemic heart failure (occluded stent) and is feasible for the development of new therapeutic approaches.
|
|
| 79. |
|
|
| 80. |
|
|
